CRISPR-mediated KLF6 targeting impaired ccRCC cell growth both in vitro and in vivo due to perturbation in the mTORC1 signalling pathway and lipid homeostasis [113]. Here, KLF6 is linked to nonpapillary renal cell carcinoma.